Related Articles
Melanoma-associated antigen expression and the efficacy of tyrosine kinase inhibitors in head and neck cancer
MAGE-A9 in head and neck cancer: Prognostic value and preclinical findings in the context of irradiation
Contrary melanoma‑associated antigen‑A expression at the tumor front and center: A comparative analysis of stage I and IV head and neck squamous cell carcinoma
Impact of MAGE-A antigens on taxane response in oral squamous cell carcinoma
MAGE‑A genes as predictors of the outcome of laryngeal squamous cell carcinoma